Technical Capabilities of the "SMART ANGEL Intra-hospital" System 's Connected Medical Device (CMD)

NCT ID: NCT04668807

Last Updated: 2020-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-31

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-operative mortality in case of scheduled surgery is 3% in France (Lancet 2013) mainly due to cardiovascular or respiratory complications, by decompensation of pre-existing pathologies.

Complications due to the medical practice are the third cause of morbidity(BMJ, 2016). More than half are preventable and are mainly observed in surgical patients. In conventional hospitalization, excluding intensive care, monitoring is done discontinuously for most of the patients, which does not allow early diagnosis of a vital cardiovascular or respiratory failure.

Diagnosis and late treatment do not allow good recovery. The early identification of a vital failure by the continuous monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) would allow faster management by the hospital staff and a reduction in immediate and possibly delayed postoperative mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The challenge of this research is to transpose in an ordinary hospitalization unit the continuous monitoring of vital functions carried out in intensive care by the continuous measurement of simple parameters using a Connected Medical Device (CMD).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Device

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Connected Medical Device Device Feasibility Post-operative mortality "SMART ANGEL intra-hospital" system

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Measurement of 3 constants (SpO2, heart rate and respiratory rate) in patients with a non-ambulatory surgical or interventional act lasting more than 2 hours whose constants are monitored by the reference device in the operating room and the Connected Medical Device.
Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Connected Medical Device

"SMART ANGEL Intra-hospital" System 's Connected Medical Device (DMC) measuring physiological parameters in the operating room

Group Type EXPERIMENTAL

Connected Medical Device

Intervention Type DEVICE

Monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) with a Connected Medical Device (DMC) in the operating room

Traditional system

Traditional wired transmission system between the sensor and the data processing device in the operating room

Group Type ACTIVE_COMPARATOR

Traditional transmission system

Intervention Type DEVICE

Monitoring of physiological parameters with a traditional wired transmission system between the sensor and the data processing device in the operating room

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Connected Medical Device

Monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) with a Connected Medical Device (DMC) in the operating room

Intervention Type DEVICE

Traditional transmission system

Monitoring of physiological parameters with a traditional wired transmission system between the sensor and the data processing device in the operating room

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Patients receiving a non-ambulatory surgical or interventional procedure lasting more than 2 hours
* Affiliation with a social security syste, beneficiarie or eligible people (excluding State Medical Assistance (AME))
* Written consent of the patient

Exclusion Criteria

* Patient carrying a multi-resistant germ and placed in isolation
* Patient's known linguistic inability to understand the study
* Non-ambulatory surgical or interventional act in an emergency situation
* Patients under legal protection : curatorship or guardianship
* Known pregnancy or nursing woman
* Patients with implantable cardiac pacemakers, implantable defibrillators or neurostimulators
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Evolucare Technologies

INDUSTRY

Sponsor Role collaborator

InES - Innovation Electronic Software

UNKNOWN

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Louis MARTY, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assistance Publique Hôpitaux de Paris - CHU Henri Mondor

Créteil, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Louis MARTY, MD, PhD

Role: CONTACT

Phone: 01 49 81 43 45

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jean-Louis MARTY, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A02197-50

Identifier Type: OTHER

Identifier Source: secondary_id

APHP190708

Identifier Type: -

Identifier Source: org_study_id